Certification Demonstrates Company’s Commitment to Industry Best Practices for Information Security
ROCKVILLE, Md., March 18, 2025 /PRNewswire/ — Health technology pioneer DrFirst, a leading provider of end-to-end medication management solutions, today announced its products have earned certified status by HITRUST for information security.
The HITRUST i1 Validated Assessment and Certification demonstrates that DrFirst solutions leverage a set of curated controls to protect against current and emerging threats, helping customers address cybersecurity challenges and remain cyber resilient over time.
All DrFirst medication management solutions are covered under this certification, including:
“Strong cybersecurity measures are essential to protecting our organization and the stakeholders who rely on us,” said G. Cameron Deemer, CEO of DrFirst. “Earning HITRUST i1 Certification for our products demonstrates our commitment to the highest standards of data protection and security, which are integral to our culture of innovation.”
A rigorous validation process confirmed that DrFirst meets the stringent security and privacy requirements outlined in the HITRUST Common Security Framework, which supports the company in effectively managing data, mitigating information risks, and demonstrating compliance with regulatory standards, including HIPAA requirements.
The certification process also involved an assessment by an external HITRUST-authorized firm, followed by HITRUST’s verification of the accuracy and quality.
“HITRUST is continually innovating to find new and creative approaches to address information security challenges,” said Jeremy Huval, Chief Innovation Officer of HITRUST. “HITRUST i1 certification is evidence that the company is at the forefront of industry best practices for information risk management and cybersecurity.”
About DrFirst
For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare workflows and help patients start and stay on therapy with end-to-end solutions that enhance prescription access, affordability, and adherence. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit DrFirst.com.
DrFirst Media Contact
Katlyn Nesvold, Amendola Communications for DrFirst
715-559-0046
knesvold@acmarketingpr.com
SOURCE DrFirst
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…